Beneficial effects of selective HDL-raising gene transfer on survival, cardiac remodelling and cardiac function after myocardial infarction in mice

Gene Therapy

Volumn 20, Issue 11, 2013, Pages 1053-1061

  Gordts, S C ^a   Muthuramu, I ^a   Nefyodova, E ^a   Jacobs, F ^a   Van Craeyveld, E ^a   De Geest, B ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

apolipoprotein A I; gene transfer; HDL; heart failure; myocardial infarction; ventricular remodeling

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 10; INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRANSFORMING GROWTH FACTOR BETA1; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CAPILLARY DENSITY; CONTROLLED STUDY; FIBROSING ALVEOLITIS; GENE TRANSFER; HEART FUNCTION; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE NECROSIS; HEART RUPTURE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

MUS;

ADENOVIRIDAE; ANIMALS; APOLIPOPROTEIN A-I; CHOLESTEROL, HDL; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEART; HEART FAILURE; HEART FUNCTION TESTS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, LDL; SURVIVAL; TRANSGENES; VENTRICULAR REMODELING;

EID: 84887478833     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2013.30     Document Type: Article

References (42)

1. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989; 79: 8-15.
2. Su YR, Ishiguro H, Major AS, Dove DE, Zhang W, Hasty AH et al. Macrophage apolipoprotein A-I expression protects against atherosclerosis in ApoE-deficient mice and up-regulates ABC transporters. Mol Ther 2003; 8: 576-583.
3. Rader DJ. Molecular regulation of HDL metabolism and function: implications for novel therapies. J Clin Invest 2006; 116: 3090-3100.
4. Kopfler WP, Willard M, Betz T, Willard JE, Gerard RD, Meidell RS. Adenovirusmediated transfer of a gene encoding human apolipoprotein A-I into normal mice increases circulating high-density lipoprotein cholesterol. Circulation 1994; 90: 1319-1327.
5. Belalcazar LM, Merched A, Carr B, Oka K, Chen KH, Pastore L et al. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia. Circulation 2003; 107: 2726-2732.
6. Van Craeyveld E, Gordts S, Jacobs F, De Geest B. Gene therapy to improve high-density lipoprotein metabolism and function. Curr Pharm Des 2010; 16: 1531-1544.
7. Wang TD, Wu CC, Chen WJ, Lee CM, Chen MF, Liau CS et al. Dyslipidemias have a detrimental effect on left ventricular systolic function in patients with a first acute myocardial infarction. Am J Cardiol 1998; 81: 531-537.
8. Kempen HJ, van Gent CM, Buytenhek R, Buis B. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function. J Lab Clin Med 1987; 109: 19-26.
9. Velagaleti RS, Massaro J, Vasan RS, Robins SJ, Kannel WB, Levy D. Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study. Circulation 2009; 120: 2345-2351.
10. Mehra MR, Uber PA, Lavie CJ, Milani RV, Park MH, Ventura HO. High-density lipoprotein cholesterol levels and prognosis in advanced heart failure. J Heart Lung Transplant 2009; 28: 876-880.
11. Iwaoka M, Obata JE, Abe M, Nakamura T, Kitta Y, Kodama Y et al. Association of low serum levels of apolipoprotein A-I with adverse outcomes in patients with nonischemic heart failure. J Card Fail 2007; 13: 247-253.
12. Frias MA, James RW, Gerber-Wicht C, Lang U. Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine- 1-phosphate. Cardiovasc Res 2009; 82: 313-323.
13. Van Linthout S, Spillmann F, Riad A, Trimpert C, Lievens J, Meloni M et al. Human apolipoprotein A-I gene transfer reduces the development of experimental diabetic cardiomyopathy. Circulation 2008; 117: 1563-1573.
14. Theilmeier G, Schmidt C, Herrmann J, Keul P, Schafers M, Herrgott I et al. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischaemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation 2006; 114: 1403-1409.
15. Erlebacher JA, Weiss JL, Weisfeldt ML, Bulkley BH. Early dilation of the infarcted segment in acute transmural myocardial infarction: role of infarct expansion in acute left ventricular enlargement. J Am Coll Cardiol 1984; 4: 201-208.
16. Eaton LW, Weiss JL, Bulkley BH, Garrison JB, Weisfeldt ML. Regional cardiac dilatation after acute myocardial infarction: recognition by two-dimensional echocardiography. N Engl J Med 1979; 300: 57-62.
17. Erlebacher JA, Weiss JL, Eaton LW, Kallman C, Weisfeldt ML, Bulkley BH. Late effects of acute infarct dilation on heart size: a two dimensional echocardiographic study. Am J Cardiol 1982; 49: 1120-1126.
18. Schuster EH, Bulkley BH. Expansion of transmural myocardial infarction: a pathophysiologic factor in cardiac rupture. Circulation 1979; 60: 1532-1538.
19. Jugdutt BI, Michorowski BL. Role of infarct expansion in rupture of the ventricular septum after acute myocardial infarction: a two-dimensional echocardiographic study. Clin Cardiol 1987; 10: 641-652.
20. Gao XM, Xu Q, Kiriazis H, Dart AM, Du XJ. Mouse model of post-infarct ventricular rupture: time course, strain- and gender-dependency, tensile strength, and histopathology. Cardiovasc Res 2005; 65: 469-477.
21. Smythies LE, White CR, Maheshwari A, Palgunachari MN, Anantharamaiah GM, Chaddha M et al. Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages. Am J Physiol Cell Physiol 2010; 298: C1538-C1548.
22. Wang B, Ansari R, Sun Y, Postlethwaite AE, Weber KT, Kiani MF. The scar neovasculature after myocardial infarction in rats. Am J Physiol Heart Circ Physiol 2005; 289: H108-H113.
23. Nofer JR, Levkau B, Wolinska I, Junker R, Fobker M, von Eckardstein A et al. Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-Associated lysosphingolipids. J Biol Chem 2001; 276: 34480-34485.
24. Seetharam D, Mineo C, Gormley AK, Gibson LL, Vongpatanasin W, Chambliss KL et al. High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ Res 2006; 98: 63-72.
25. Feng Y, Jacobs F, Van Craeyveld E, Brunaud C, Snoeys J, Tjwa M et al. Human ApoA-I transfer attenuates transplant arteriosclerosis via enhanced incorporation of bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008; 28: 278-283.
26. Feng Y, van Eck M, Van Craeyveld E, Jacobs F, Carlier V, Van Linthout S et al. Critical role of scavenger receptor-BI-expressing bone marrow-derived endothelial progenitor cells in the attenuation of allograft vasculopathy after human apo A-I transfer. Blood 2009; 113: 755-764.
27. Gordts SC, Van Craeyveld E, Muthuramu I, Singh N, Jacobs F, De Geest B. Lipid lowering and HDL raising gene transfer increase endothelial progenitor cells, enhance myocardial vascularity, and improve diastolic function. PLoS One 2012; 7: e46849.
28. Rehman J, Li J, Orschell CM, March KL. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003; 107: 1164-1169.
29. Hofmann U, Beyersdorf N, Weirather J, Podolskaya A, Bauersachs J, Ertl G et al. Activation of CD4 T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice. Circulation 2012; 125: 1652-1663.
30. Matsumoto K, Ogawa M, Suzuki J, Hirata Y, Nagai R, Isobe M. Regulatory T lymphocytes attenuate myocardial infarction-induced ventricular remodeling in mice. Int Heart J 2011; 52: 382-387.
31. Roord ST, de Jager W, Boon L, Wulffraat N, Martens A, Prakken B et al. Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4CD25Foxp3 regulatory T cells. Blood 2008; 111: 5233-5241.
32. Burt RK, Marmont A, Oyama Y, Slavin S, Arnold R, Hiepe F et al. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum 2006; 54: 3750-3760.
33. Burt RK, Loh Y, Pearce W, Beohar N, Barr WG, Craig R et al. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 2008; 299: 925-936.
34. Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circ Res 2012; 110: 159-173.
35. Jacobs F, Snoeys J, Feng Y, Van Craeyveld E, Lievens J, Armentano D et al. Direct comparison of hepatocyte-specific expression cassettes following adenoviral and nonviral hydrodynamic gene transfer. Gene Ther 2008; 15: 594-603.
36. Van Linthout S, Lusky M, Collen D, De Geest B. Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector. Gene Ther 2002; 9: 1520-1528.
37. Snoeys J, Mertens G, Lievens J, van Berkel T, Collen D, Biessen EA et al. Lipid emulsions potently increase transgene expression in hepatocytes after adenoviral transfer. Mol Ther 2006; 13: 98-107.
38. Van Craeyveld E, Gordts SC, Nefyodova E, Jacobs F, De Geest B. Regression and stabilization of advanced murine atherosclerotic lesions: a comparison of LDL lowering and HDL raising gene transfer strategies. J Mol Med 2011; 89: 555-567.
39. Van Craeyveld E, Jacobs F, Gordts SC, De Geest B. Low-density lipoprotein receptor gene transfer in hypercholesterolemic mice improves cardiac function after myocardial infarction. Gene Ther 2012; 19: 860-871.
40. Jacobs F, Van Craeyveld E, Feng Y, Snoeys J, De Geest B. Adenoviral low density lipoprotein receptor attenuates progression of atherosclerosis and decreases tissue cholesterol levels in a murine model of familial hypercholesterolemia. Atherosclerosis 2008; 201: 289-297.
41. Van Linthout S, Collen D, De Geest B. Effect of promoters and enhancers on expression, transgene DNA persistence, and hepatotoxicity after adenoviral gene transfer of human apolipoprotein A-I. Hum Gene Ther 2002; 13: 829-840.
42. Junqueira LC, Bignolas G, Brentani RR. Picrosirius staining plus polarisation microscopy, a specific method for collagen detection in tissue sections. Histochem J 1979; 11: 447-455.